This publication has been discontinued on September 9, 2011.
Abstract
Cancer Vaccines - Pipeline Analysis and Market Forecasts to 2016
Summary
GlobalData, the industry analysis specialist’s new report, “Cancer
Vaccines - Pipeline Analysis and Market Forecasts to 2016” is an
essential source of information and analysis on the global cancer vaccines
market. The report identifies the key trends shaping and driving the global
cancer vaccines market. The report also provides insight on the prevalent
competitive landscape and the emerging players expected to bring significant
shift in the market positioning of the existing market leaders. Most
importantly, the report provides valuable insight on the pipeline products
within the global cancer vaccines sector.
This report is built using data and information sourced from proprietary
databases, primary and secondary research and in house analysis by
GlobalData’s team of industry experts.
Scope
The scope of the report includes:
- Annualized global cancer vaccines
market revenues data from 2000 to 2009, forecast forward for 7 years to 2016.
- Geographic markets covered in this report include the US, the UK,
Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data
providing a split across different phases, mechanism of action being developed
and emerging trends.
- Analysis of the current and future market
competition in the global cancer vaccines market.
- Insightful review of
the key industry drivers, restraints and challenges. Each trend is
independently researched to provide qualitative analysis of its
implications.
- Key topics covered include strategic competitor
assessment, market characterization, unmet needs and implications for future
market associated with cancer vaccines.
Reasons to buy
The report will enhance your decision making capability in a more rapid and
time sensitive manner. It will allow you to:
- Develop and design your
in-licensing and out-licensing strategies through review of pipeline products
and technologies and by identifying companies with the most robust
pipeline.
- Develop business strategies by understanding the trends
shaping and driving the global cancer vaccines market.
- Drive revenues
by understanding key trends, innovative products and technologies, market
segments and companies likely to impact the global cancer vaccines market in
future.
- Formulate effective sales and marketing strategies by
understanding the competitive landscape and by analyzing the performance of
various competitors.
- Identify emerging players with potentially strong
product portfolio and create effective counter-strategies to gain
competitive advantage.
- Organize your sales and marketing efforts by
identifying the market categories and segments that present maximum
opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global cancer vaccines market
landscape? - Identify, understand and capitalize.
Table of Contents
1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2
Global Cancer Vaccines Market: Market Characterizations 6
2.1 Overview
6
2.2 Global Cancer Vaccines Market Size 6
2.3 Global Cancer Vaccines
Market Forecast and CAGR 7
2.4 Drivers and Barriers for the Global Cancer
Vaccines Market 7
2.4.1 Drivers for the Global Cancer Vaccines Market
7
2.4.2 Barriers for the Global Cancer Vaccines Market 8
2.5
Opportunity and Unmet Need 8
2.6 Key Takeaway 9
3 Cancer Vaccines
Market: Competitive Assessment 10
3.1 Overview 10
3.2 Strategic
Competitor Assessment 10
3.3 Product Profile for the Marketed Vaccines in
the Cancer Market 10
3.3.1 Gardasil 10
3.3.2 Cervarix 12
3.3.3
Oncophage (vitespen) 13
3.4 Key Takeaway 14
4 Cancer Vaccines Market:
Pipeline Assessment 15
4.1 Overview 15
4.2 Strategic Pipeline
Assessment 15
4.2.1 Technology Trends Analytic Framework 15
4.3 Cancer
Vaccines Pipeline - Promising Vaccines under Clinical Development 17
4.4 Molecule Profile for Promising Cancer Vaccines under Clinical Development
18
4.4.1 Provenge (sipuleucel-T) 18
4.4.2 Stimuvax 19
4.4.3
OncoVAX 20
4.4.4 MAGE-A3 ASCI 21
4.4.5 Oncovex (GM-CSF) 22
4.5
Global Cancer Vaccines Market - Clinical Pipeline by Vaccine Type 24
4.6 Global Cancer Vaccines Pipeline - Pipeline by Clinical Phases of
Development 24
4.6.1 Cancer Vaccines - Regulatory Filing and Phase
III Clinical Pipeline 25
4.6.2 Cancer Vaccines Market - Phase II
Clinical Pipeline 26
4.6.3 Cervical Cancer Therapeutics - Phase I
Clinical Pipeline 29
4.6.4 Cancer Vaccines - Preclinical Pipeline
34
4.6.5 Cancer Vaccines - Discovery Pipeline 34
4.7 Key
Takeaway 34
5 Cancer Vaccines Market: Implications for Future Market
Competition 35
6 Global Cancer Vaccines Market: Prominent Market Players
37
6.1 Introduction 37
6.2 Dendreon Corporation 37
6.2.1 Overview
37
6.2.2 Financial Performance 37
6.2.3 Business Description 38
6.2.4 Cancer Vaccines Product Portfolio 38
6.3 Vaccinogen Inc. 39
6.3.1 Overview 39
6.3.2 Cancer Vaccines Product Portfolio 40
6.4
GlaxoSmithKline Plc. 41
6.4.1 Overview 41
6.4.2 Oncology Portfolio
42
6.4.3 Cancer Vaccines Product Portfolio 43
7 Global Cancer Vaccines
Market: Appendix 45
7.1 Market Definitions 45
7.2 Abbreviations 45
7.3 Research Methodology 46
7.3.1 Coverage 46
7.3.2 Secondary Research
47
7.3.3 Forecasting 47
7.3.4 Primary Research 49
7.3.5 Expert
Panels Validation 50
7.4 Contact Us 50
7.5 Disclaimer 50
7.6
Sources 50
1.1 List of Tables
Table 1: Cancer Vaccines Market,
Global, Market Revenue ($bn), 2007-2016 7
Table 2: Marketed
Vaccines Comparison in the Cancer Vaccines Market, 2010 14
Table 3:
Cancer Vaccines Pipeline - Most Promising Vaccines under Clinical
Development, 2010 17
Table 4: Global Cancer Vaccines Market -
Regulatory Filling and Phase III Clinical Pipeline, January 2010 25
Table
5: Global Cancer Vaccines Market - Phase II Clinical Pipeline, January
2010 26
Table 6: Global Cancer Vaccines Market - Phase I Clinical
Pipeline, January 2010 29
Table 7: Global Cancer Vaccines Market -
Preclinical Pipeline, January 2010 34
Table 8: Global Cancer Vaccines
Market - Discovery Pipeline, January 2010 34
Table 9: Dendreon
Corporation - Oncology Pipeline Products, January 2010 38
Table 10:
Vaccinogen Inc. - Oncology Pipeline Products, January 2010 40
Table
11: GlaxoSmithKline Plc. - Oncology Pipeline Products, January 2010
42
1.2 List of Figures
Figure 1: Cancer Vaccines Market, Global,
Revenue Forecasts, 2007-2016 7
Figure 2: Opportunity and Unmet Need
in the Cancer Vaccines Market, 2010 8
Figure 3: Strategic Competitor
Assessment of the Vaccines in the Global Cancer Vaccines Market, 2010 10
Figure 4: Technology Trends Analytic Framework of the Global Cancer Vaccines
Phase II and Phase III Pipeline, January 2010 15
Figure 5: Technology
Trends Analytic Framework of the Global Cancer Vaccines Phase II and Phase
III Pipeline - Description, January 2010 16
Figure 6: Global Cancer
Vaccines Market - Clinical Pipeline by Vaccine Type, 2010 24
Figure
7: Cancer Vaccines Pipeline by Phase of Clinical Development, January 2010
24
Figure 8: Implications for Future Market Competition in the Cancer
Vaccines Market, 2010 35
Figure 9: Global Cancer Vaccines Therapeutics
Market - Clinical Pipeline by Company, 2010 37
Figure 10:
GlobalData Methodology 46
Figure 11: GlobalData Market Forecasting Model
49
